lenvatinib,sunitinib,everolimus,pembrolizumab
merck,pfizer,eisai
['bladder', 'clear trial', 'gu ', 'rcc,(-irccs),(-srcc),(-urcc)']
 presenting data from the clear trial in #rcc with co-chairing the oral kidney/bladder session at #asco23 #asco2023. two great gu oncologists representing their community clinics and . our gu committee is proud! 
Assistant Director of Genitourinary Research at Sarah Cannon Research Institute. GU Medical Oncologist at Tennessee Oncology. All tweets and views are my own.